Crossmark

CCK-1R-selective and non-selective cholecystokinin antagonists, lorglumide, and proglumide increased toxicity of carboplatin to granulocyte–macrophage progenitor cells (CFU-GM) of bone marrow of rats

Crossref DOI link: https://doi.org/10.1007/s00210-025-04391-6

Published Online: 2025-06-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pelles-Taskó, Beáta

Varga, Angelika

Géresi, Krisztina

Juhász, Béla

Szilvássy, Zoltán

Benkő, Ilona https://orcid.org/0000-0003-1290-5678
Funding

Funding for this research was provided by:

European Regional Development Fund (GINOP-2.3.4.-15-2016-00002, GINOP-2.3.4.-15-2016-00002, GINOP-2.3.4.-15-2016-00002)

Ministry of Innovation of Hungary (TKP2021-EGA, TKP2021-EGA)

University of Debrecen
License Information

Text and Data Mining valid from 2025-06-30

Version of Record valid from 2025-06-30
More Information

Article History

Received: 4 April 2025

Accepted: 12 June 2025

First Online: 30 June 2025

Declarations

:

: The experiments performed in the present work conform to the guiding principles of the European Community for the care and use of laboratory animals regulated under Directive 2010/63/EU and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85–23, revised 1996). All experimental protocols applied and have been approved by the Ethics Committee of the University of Debrecen, Hungary (approval number: 13/2022/DEMÁB).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below